Skip to content
★ Sign in to follow
AV

Atlas Venture Fund XII, L.P.

Related company / holding
Jade Biosciences, Inc.Vigil Neuroscience, Inc.
Total declarations
9
Companies
2
▲ Purchases (2 ops.)
€12.9M
▼ Sales (0 ops.)
—

Latest filing published 07 Aug 2025 for Vigil Neuroscience, Inc..

Filing timeline

BuySale
Atlas Venture Fund XII, L.P.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 06 Jul 2021 · 1951 days ago · €6.3M
    -9.8%
    Entry US$600.95 · Close at T+365 US$542.15

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Atlas Venture Fund XII, L.P.: trading record in brief

Atlas Venture Fund XII, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Vigil Neuroscience, Inc. and Jade Biosciences, Inc. In total, 9 filings cover trades dated from 2 July 2021 to 5 August 2025.

No open-market sale appears; the market trades are 2 purchases worth €12.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The record was last updated on 7 August 2025 with a transaction in Vigil Neuroscience, Inc. The clock since the last published purchase (11 January 2022) now reads 1,762 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Atlas Venture Fund XII, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations